Unique ID issued by UMIN | UMIN000011765 |
---|---|
Receipt number | R000013757 |
Scientific Title | Study of the clinical effects by the central supply method of the acetic acid-free dialytic fluid |
Date of disclosure of the study information | 2013/09/17 |
Last modified on | 2013/09/14 12:55:31 |
Study of the clinical effects by the central supply method of the acetic acid-free dialytic fluid
clinical effects of the acetic acid-free dialytic fluid
Study of the clinical effects by the central supply method of the acetic acid-free dialytic fluid
clinical effects of the acetic acid-free dialytic fluid
Japan |
end-stage renal failure
Nephrology |
Others
NO
In 2007, first acetic acid-free dialytic fluid (car placard) was released in a country. The car placard has a metabolic acidotic superior correction effect, and the dialysis that National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (K/DOQI) guideline "which the HCO3 density should maintain in blood before dialysis of the hemodialysis patient than 22 mEq/L" recommends is possible. We examine an effect to give a clinical response of acetic acid dialytic fluid and the acetic acid-free dialytic fluid in the central supply method and antioxidant ability.
Efficacy
Confirmatory
Pragmatic
Not applicable
For a hemodialysis patient, we examine a 12-month clinical response of acetic acid-free dialytic fluid after use in acetic acid dialytic fluid for six months. Examination item are dialysis efficiency (Kt/V), a circulation change (mean blood pressure and the pulse), nourishment dialyzing are in a state (serum protein and albumin, nPCR), acidotic improvement effect (pH, HCO3-, BE).
For a hemodialysis patient, we measure a 12-month oxidation stress marker of acetic acid-free dialytic fluid after use in acetic acid dialytic fluid for six months. Examination item are blood reduced glutathione/oxidized glutathione ratio and serum MDA-LDL.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Active
1
Treatment
Medicine |
six months of Acetic acid component dialytic fluid use, and then 12 months of acetic acid-free dialytic fluid use
20 | years-old | <= |
Not applicable |
Male and Female
end-stage renal failure patients with stable outpatient maintenance hemodialysis 20 years or older
hemodialysis patients without any cancer or acute Inflammation
30
1st name | |
Middle name | |
Last name | Akira Tsuji |
National Defense Medical College Hospital
Department of Blood Purification
3-2 Namiki, Tokorozawa Saitma, Japan
04-2995-1511
futebol@ndmc.ac.jp
1st name | |
Middle name | |
Last name | Kaori Ishizeki |
National Defense Medical College Hospital
Department of Blood Purification
3-2 Namiki, Tokorozawa Saitma, Japan
04-2995-1511
halfmoon@ndmc.ac.jp
National Defense Medical College
Foundation for Promotion of Defense Medicine
Non profit foundation
Japan
NO
防衛医科大学校病院(埼玉県) National Defense Medical College Hospital (Saitama)
2013 | Year | 09 | Month | 17 | Day |
Published
58th Congress of the Japanese Society for Dialysis therapy
Acetic acid-free dialytic fluid accepted meaningful improvement of acidotic revision, a nourishment state and anemia. By the long usage of the acetic acid-free dialytic fluid, blood GSH/GSSG was improved significantly, and plasma homocysteine significantly decreased. Thus, an effect to prevent the serious complications in the chronic hemodialysis patient is expected.
Completed
2010 | Year | 10 | Month | 21 | Day |
2010 | Year | 11 | Month | 01 | Day |
2012 | Year | 06 | Month | 03 | Day |
2012 | Year | 07 | Month | 25 | Day |
2012 | Year | 08 | Month | 05 | Day |
2012 | Year | 10 | Month | 04 | Day |
2013 | Year | 09 | Month | 14 | Day |
2013 | Year | 09 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013757